PT72573A - Process for the preparation of novel animinium salts and its 5-(cyano or carbamyl)-/3,4-bipyridin/-6(1h)-one derivates - Google Patents

Process for the preparation of novel animinium salts and its 5-(cyano or carbamyl)-/3,4-bipyridin/-6(1h)-one derivates

Info

Publication number
PT72573A
PT72573A PT72573A PT7257381A PT72573A PT 72573 A PT72573 A PT 72573A PT 72573 A PT72573 A PT 72573A PT 7257381 A PT7257381 A PT 7257381A PT 72573 A PT72573 A PT 72573A
Authority
PT
Portugal
Prior art keywords
benyridin
animinium
carbamyl
derivates
cyano
Prior art date
Application number
PT72573A
Other languages
English (en)
Other versions
PT72573B (en
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Publication of PT72573A publication Critical patent/PT72573A/pt
Publication of PT72573B publication Critical patent/PT72573B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/53Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84Nitriles
    • C07D213/85Nitriles in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT72573A 1980-02-26 1981-02-25 Process for the preparation of novel animinium salts and its 5-(cyano or carbamyl)-<3,4-bipyridin>-6(1h)-one derivates PT72573B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/124,808 US4264609A (en) 1980-02-26 1980-02-26 N-[3-Dimethylamino-2-(4-pyridinyl)-2-propenylidene]-N-methylmethaniminium chloride hydrochloride, its use in preparing 5-(cyano or carbamyl)-[3,4'-bipyridin]-6(1H)-one and its use as a cardiotonic

Publications (2)

Publication Number Publication Date
PT72573A true PT72573A (pt) 1981-03-01
PT72573B PT72573B (en) 1982-02-12

Family

ID=22416880

Family Applications (1)

Application Number Title Priority Date Filing Date
PT72573A PT72573B (en) 1980-02-26 1981-02-25 Process for the preparation of novel animinium salts and its 5-(cyano or carbamyl)-<3,4-bipyridin>-6(1h)-one derivates

Country Status (28)

Country Link
US (1) US4264609A (pt)
JP (1) JPS56128758A (pt)
KR (2) KR840002067B1 (pt)
AR (1) AR230630A1 (pt)
AT (2) AT380237B (pt)
AU (1) AU541644B2 (pt)
BE (1) BE887663A (pt)
CA (1) CA1128523A (pt)
CH (1) CH647509A5 (pt)
DE (1) DE3107306A1 (pt)
DK (1) DK171253B1 (pt)
ES (1) ES499776A1 (pt)
FI (1) FI76787C (pt)
FR (1) FR2476646A1 (pt)
GB (1) GB2070600B (pt)
HK (1) HK71789A (pt)
IE (1) IE51696B1 (pt)
IL (1) IL62161A (pt)
IT (1) IT1210992B (pt)
LU (1) LU83169A1 (pt)
MX (1) MX6908E (pt)
NL (1) NL192109C (pt)
NO (1) NO156689C (pt)
NZ (1) NZ196282A (pt)
PH (2) PH19904A (pt)
PT (1) PT72573B (pt)
SE (2) SE437514B (pt)
ZA (1) ZA811124B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE77817T1 (de) 1985-04-30 1992-07-15 Dresden Arzneimittel 3-cyan-pyridine, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4072746A (en) * 1975-10-14 1978-02-07 Sterling Drug Inc. 3-Amino-5-(pyridinyl)-2(1H)-pyridinones
US4004012A (en) * 1975-10-14 1977-01-18 Sterling Drug Inc. 3-Cyano-5-(pyridinyl)-2(1H)-pyridinones

Also Published As

Publication number Publication date
NO810639L (no) 1981-08-27
ATA88581A (de) 1985-09-15
SE8402727L (sv) 1984-05-21
FI76787C (fi) 1988-12-12
MX6908E (es) 1986-11-07
IT1210992B (it) 1989-09-29
IT8119952A0 (it) 1981-02-24
AT380236B (de) 1986-04-25
CA1128523A (en) 1982-07-27
FI76787B (fi) 1988-08-31
PT72573B (en) 1982-02-12
DK83981A (da) 1981-08-27
SE8101205L (sv) 1981-08-27
NL8100922A (nl) 1981-09-16
CH647509A5 (fr) 1985-01-31
FI810582L (fi) 1981-08-27
DK171253B1 (da) 1996-08-12
NL192109B (nl) 1996-10-01
US4264609A (en) 1981-04-28
IL62161A (en) 1984-06-29
FR2476646B1 (pt) 1984-08-17
SE452764B (sv) 1987-12-14
DE3107306A1 (de) 1981-12-17
FR2476646A1 (fr) 1981-08-28
IL62161A0 (en) 1981-03-31
PH17145A (en) 1984-06-04
IE810397L (en) 1981-08-26
JPH0141626B2 (pt) 1989-09-06
DE3107306C2 (pt) 1990-11-29
IE51696B1 (en) 1987-02-18
ZA811124B (en) 1982-03-31
NL192109C (nl) 1997-02-04
AU541644B2 (en) 1985-01-17
NO156689C (no) 1987-11-04
SE8402727D0 (sv) 1984-05-21
HK71789A (en) 1989-09-14
LU83169A1 (fr) 1981-09-11
JPS56128758A (en) 1981-10-08
AR230630A1 (es) 1984-05-31
NZ196282A (en) 1983-12-16
ATA305683A (de) 1985-09-15
PH19904A (en) 1986-08-13
GB2070600A (en) 1981-09-09
AU6748781A (en) 1981-09-03
GB2070600B (en) 1984-07-11
BE887663A (fr) 1981-08-25
NO156689B (no) 1987-07-27
AT380237B (de) 1986-04-25
KR840002066B1 (ko) 1984-11-09
KR830005143A (ko) 1983-08-03
SE437514B (sv) 1985-03-04
ES499776A1 (es) 1984-06-16
KR840002067B1 (ko) 1984-11-09

Similar Documents

Publication Publication Date Title
NO811731L (no) Fremgangsmaate for fremstilling av imidazo-rifamycin-derivater
NO813678L (no) Fremgangsmaate for fremstilling av karbostyrilderivater
PT80231A (en) Process for the preparation of nitromethylene derivatives having an insecticidal effect
GR64431B (en) Method for the preparation of new 4-amino 5-alkylsulfonyl orthoanisamides derivatives
NO810765L (no) Fremgangsmaate for fremstilling av farmasoeytisk aktive karbostyrilderivater.
NO820253L (no) Fremgangsmaate for fremstilling av furo-(3,4-c)pyridin-derivater
NO841322L (no) Fremgangsmaate for fremstilling av furo (3,4-c)-pyridin-derivater
ES499299A0 (es) Procedimiento de preparacion de derivados de la trimetoxi- 3,4,5 cinamoilpiperacina
NO864108L (no) Fremgangsmaate for fremstilling av nye flavon-derivater.
AR229519A1 (es) Procedimiento de preparacion de derivados de 2,3-dihidro-9-fenil-1h-pirazolo(1,2-a)-indazolio
NO892204D0 (no) Fremgangsmaate for fremstilling av imidazokinoxalin-forbindelser.
NO813477L (no) Fremgangsmaate for fremstilling av karbostyrilderivater
NO801171L (no) Fremgangsmaate for fremstilling av fenylglycylklorid-hydroklorid-derivater.
NO157143C (no) Fremgangsmaate for fremstilling av karbapen-2-em-derivater.
PT87643A (pt) Process for the preparation of pyran compounds
NO892977D0 (no) Fremgangsmaate for fremstilling av nye s-adenosylmethionin-derivater.
ES536814A0 (es) Procedimiento de preparacion de nuevos derivados de 1, 3-dihidro-6-metil-7-hidroxi-furo-(3, 4-c)-piridina
PT72573A (pt) Process for the preparation of novel animinium salts and its 5-(cyano or carbamyl)-/3,4-bipyridin/-6(1h)-one derivates
NO812842L (no) Fremgangsmaate for fremstilling av aminoacetonitil-derivater
GR64493B (en) Method for the preparation of methalylo-sulfonic natrium
NO854577L (no) Fremgangsmaate for fremstilling av nye tienopyridinderivater.
NO154193C (no) Fremgangsmaate for fremstilling av monohydratisert picotamid
NO820767L (no) Fremgangsmaate for fremstilling av tetrahydropyridinderivater
FI91069B (fi) Menetelmä 5-C-hydroksimetyylialdoheksoosipohjaisten yhdisteiden valmistamiseksi
FI893478A (fi) Menetelmä uusien kysteiinijohdannaisten valmistamiseksi

Legal Events

Date Code Title Description
PC3A Transfer or assignment

Free format text: 980513 SANOFI PHARMACEUTICALS, INC. US

PD3A Change of proprietorship
PD3A Change of proprietorship

Owner name: SANOFI-SYNTHELABO INC.

Effective date: 20000209